BSSP (Cantech Holding) Total Stockholders Equity: $-0.86 Mil (As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cantech Holding Total Stockholders Equity?

Cantech Holding BSSP -99.50% Total Stockholders Equity is $-0.86 Mil as of Sep. 2015.

Cantech Holding's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $-0.86 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cantech Holding's Book Value per Share for the quarter that ended in Sep. 2015 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cantech Holding's Debt-to-Equity for the quarter that ended in Sep. 2015 was -0.44.

Cantech Holding  (OTCPK:BSSP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cantech Holding's Book Value per Share for the quarter that ended in Sep. 2015 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-0.862-0)/57.439
=-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cantech Holding's Debt-to-Equity for the quarter that ended in Sep. 2015 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.351 + 0.026) / -0.862
=-0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantech Holding Total Stockholders Equity Related Terms

Cantech Holding Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cantech Holding's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantech Holding Total Stockholders Equity Chart

Cantech Holding Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Total Stockholders Equity
-0.08 -0.02 -0.12 -0.41

Cantech Holding Quarterly Data
Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -0.41 -0.58 -1.01 -0.86
What does a Total Stockholders Equity of $-0.86 Mil mean?
Cantech Holding (BSSP) has a Total Stockholders Equity of $-0.86 Mil as of Sep. 2015. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cantech Holding and its competitors.
Is Cantech Holding's Total Stockholders Equity too high?
Cantech Holding's current Total Stockholders Equity is $-0.86 Mil.
How does Cantech Holding's Total Stockholders Equity compare to HSTC and NTRR?
Cantech Holding's Total Stockholders Equity of $-0.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cantech Holding and its competitors. Cantech Holding's current Total Stockholders Equity is $-0.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantech Holding stock overvalued right now?
Cantech Holding (BSSP) has a current Total Stockholders Equity of $-0.86 Mil. The current Total Stockholders Equity is $-0.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Cantech Holding (BSSP), the current Total Stockholders Equity is $-0.86 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantech Holding Business Description

Address 120 W Pomona Avenue, Monrovia, CA, USA, 91016
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.